Norges Bank acquired a new position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 508,055 shares of the company's stock, valued at approximately $25,403,000. Norges Bank owned about 1.11% of Azenta at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in the business. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Azenta by 14.9% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,446 shares of the company's stock worth $225,000 after acquiring an additional 576 shares in the last quarter. Zions Bancorporation N.A. boosted its stake in Azenta by 15.8% during the 4th quarter. Zions Bancorporation N.A. now owns 27,678 shares of the company's stock valued at $1,384,000 after purchasing an additional 3,774 shares during the last quarter. Segall Bryant & Hamill LLC bought a new stake in Azenta during the 4th quarter worth approximately $14,405,000. Prudential Financial Inc. raised its stake in shares of Azenta by 164.9% in the fourth quarter. Prudential Financial Inc. now owns 45,868 shares of the company's stock worth $2,293,000 after purchasing an additional 28,553 shares during the last quarter. Finally, LPL Financial LLC raised its stake in shares of Azenta by 31.4% in the fourth quarter. LPL Financial LLC now owns 50,342 shares of the company's stock worth $2,590,000 after purchasing an additional 12,033 shares during the last quarter. 99.08% of the stock is owned by institutional investors.
Azenta Stock Up 0.7 %
Azenta stock traded up $0.18 during mid-day trading on Friday, reaching $26.71. 1,111,613 shares of the company's stock were exchanged, compared to its average volume of 630,464. The business's fifty day simple moving average is $39.42 and its 200 day simple moving average is $44.75. Azenta, Inc. has a one year low of $25.36 and a one year high of $63.58. The firm has a market capitalization of $1.22 billion, a PE ratio of -8.96 and a beta of 1.66.
Azenta (NASDAQ:AZTA - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. On average, sell-side analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on the company. Needham & Company LLC lifted their target price on Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a research report on Thursday, February 6th. TD Cowen raised shares of Azenta to a "hold" rating in a report on Thursday, February 27th. Stephens reiterated an "overweight" rating and issued a $60.00 target price on shares of Azenta in a report on Thursday, January 2nd. Finally, Evercore ISI boosted their price target on shares of Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a report on Thursday, February 6th.
Read Our Latest Stock Analysis on Azenta
About Azenta
(
Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Read More

Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.